▶Flip②▶the SOCIAL CURRENT SEE



NOW ▶Flip2CANswer♥WORTH another microblog created, edited and archived by ALTACITIES® http://altacities.com Flip2 ▶ the SCS * (Social Current See), including what's up with our 8-year MCL survival journey ▶Content archived on Blogger, Facebook, Flipboard, G+, Linkedin, ShowYou, Storify, Twitter, and YouTube

Monday, October 6, 2014

Random stories from the canswerists*

More than 10.1 million sites arrive on screen once a web search is conducted, as in this BING search of mine.  Of course, no one would attempt to follow all of these sites.  Many are written and edited by actual survivors and many other are hosted by corporate entities like Blog for a Cure and HEALTHLINE.  I try to check in periodically with the few bloggers who came to my attention since my first DX with mantle cell lymphoma in April 2006.

Flip②▶STORIFYFLIPBOARDBLOGGERINsync®

photo
                 

Monday, September 22, 2014

Daily aspirin may prevent cancer

Dr. Keith Souter worked as a family doctor for almost 30 years, and was involved in several national trials, including one of the major studies on aspirin. He has been a medical columnist for 28 years, is a medical journalist, and still practices medicine. Professor Tom Meade, FRS, is the coauthor of several seminal aspirin studies.

Flip②▶STORIFYFLIPBOARDBLOGGER

photo
                 

Friday, August 22, 2014

Watching the sleuths who follow our DNA



August 23 is the seventh anniversary of my unrelated donor stem cell transplant to treat and cure an aggressive form of mantel cell lymphoma (MCL).  Those to study this process know that matching one's DNA to the donor is a critical step.  That must by why the topic of DNA catches my fancy.

Flip②▶STORIFY ♥FLIPBOARD ★BLOGGER


             
Flip② ▶ ALTACITIES.COM (Today's Tweets Are Tomorrow's Posts)

Sunday, August 10, 2014

Canswerists* biopsy new CA classifications

Those whose lives revolve around cancer treatment, both the caregivers and the survivors, know that change in therapies, drugs, and procedures is constant.  A year is a lifetime.  One hundred years is an eternity.  That's why it is astounding that researchers and scientists have just announced a new classification system for cancer.

According to the lead source in this 'social current see,' "The old system classifying cancer by the tissue of where it arose is outdated. It's been in existence for over 100 years now, and we know it doesn't merit the true nature of the cancer," said Dr. Christopher Benz, a professor at the Buck Institute for Research on Aging in Novato and co-senior author of the study.

Flip②▶STORIFYFLIPBOARDBLOGGER

Flip②▶SUBSCRIPTION 
 
             
Flip② ▶ ALTACITIES.COM (Today's Tweets Are Tomorrow's Posts)